These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 3019293)
21. Specificity of monoclonal antibodies to an EBV transformed B-cell line. Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556 [TBL] [Abstract][Full Text] [Related]
22. Antibody production of a human EBV-transformed B cell line and its heterohybridoma and trioma cell line descendants in different culture systems. Gustafsson B; Hinkula J Hum Antibodies Hybridomas; 1994; 5(3-4):98-104. PubMed ID: 7756584 [TBL] [Abstract][Full Text] [Related]
23. [Human monoclonal antibodies with human-mouse hybridomas]. Naoe T; Kato K; Shiku H; Yamada K Gan To Kagaku Ryoho; 1983 Dec; 10(12):2575-81. PubMed ID: 6606396 [TBL] [Abstract][Full Text] [Related]
24. Construction of human monoclonal antibodies against rabies NS-protein antigen by Epstein-Barr virus transformation. Gebauer W; Lindl T Arzneimittelforschung; 1990 Jun; 40(6):718-22. PubMed ID: 2168706 [TBL] [Abstract][Full Text] [Related]
25. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. Buchacher A; Predl R; Strutzenberger K; Steinfellner W; Trkola A; Purtscher M; Gruber G; Tauer C; Steindl F; Jungbauer A AIDS Res Hum Retroviruses; 1994 Apr; 10(4):359-69. PubMed ID: 7520721 [TBL] [Abstract][Full Text] [Related]
26. Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells. Rosén A; Persson K; Klein G J Immunol; 1983 Jun; 130(6):2899-902. PubMed ID: 6189902 [TBL] [Abstract][Full Text] [Related]
27. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. Yokochi T; Holly RD; Clark EA J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961 [TBL] [Abstract][Full Text] [Related]
28. A human monoclonal antibody to cytomegalovirus (CMV). Emanuel D; Gold J; Colacino J; Lopez C; Hammerling U J Immunol; 1984 Oct; 133(4):2202-5. PubMed ID: 6088634 [TBL] [Abstract][Full Text] [Related]
29. [A strategy for the production of human monoclonal antibodies]. Chiba J Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441 [TBL] [Abstract][Full Text] [Related]
30. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion. Perkins S; Foung SK Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401 [No Abstract] [Full Text] [Related]
31. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus. Brown NA; Miller G J Immunol; 1982 Jan; 128(1):24-9. PubMed ID: 6274955 [TBL] [Abstract][Full Text] [Related]
32. Human monoclonal autoimmune antibody produced in vitro: rheumatoid factor generated by Epstein-Barr virus-transformed cell line. Steinitz M; Tamir S Eur J Immunol; 1982 Feb; 12(2):126-33. PubMed ID: 6281026 [TBL] [Abstract][Full Text] [Related]
33. Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients. Lundgren K; Wahlgren M; Troye-Blomberg M; Berzins K; Perlmann H; Perlmann P J Immunol; 1983 Oct; 131(4):2000-3. PubMed ID: 6311902 [TBL] [Abstract][Full Text] [Related]
34. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes. Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769 [TBL] [Abstract][Full Text] [Related]
35. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines. Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865 [TBL] [Abstract][Full Text] [Related]
36. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma. Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420 [TBL] [Abstract][Full Text] [Related]
37. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines. Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082 [TBL] [Abstract][Full Text] [Related]
38. In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes. Desgranges C; Lenoir G; de-Thé G; Seigneurin JM; Hilgers J; Dubouch P Biomedicine; 1976 Dec; 25(9):349-52. PubMed ID: 187263 [TBL] [Abstract][Full Text] [Related]
39. Production of human monoclonal antibodies by the epstein-barr virus method. Steinitz M Methods Mol Biol; 2014; 1060():111-22. PubMed ID: 24037838 [TBL] [Abstract][Full Text] [Related]